| For: | Siddiqui AH, Batool F, Khan S, Rizvi SS, Usman S, Jawed H, Ali MH, Zehra T, Adil AR, Anwar M, Hanif A, Hassan SK, Noble MW, Moeed A, Surani S. Safety and efficacy of sodium bicarbonate for treating metabolic acidosis in chronic kidney disease: A systematic review and meta-analysis. World J Nephrol 2025; 14(1): 101078 [PMID: 40134641 DOI: 10.5527/wjn.v14.i1.101078] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v14/i1/101078.htm |
| Number | Citing Articles |
| 1 |
Beverley Beynon-Cobb, Wesley Visser, Ewout J. Hoorn, Andrew Morris. Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations. American Journal of Kidney Diseases 2026; doi: 10.1053/j.ajkd.2026.03.047
|
| 2 |
Percy Herrera-Añazco, Miguel A. Huayta-Cortez, Juan R. Ulloque-Badaracco, Christian N. Rojas, Nella Altamirano-Cabezas, Vicente A. Benites-Zapata. Effects of correcting metabolic acidosis in chronic kidney disease patients: An umbrella review. Sage Open Chronic Disease 2026; 17 doi: 10.1177/27558428251411463
|
| 3 |
Laura Desai, Jyoti Baharani. Optimising acid-base balance in patients with advanced chronic kidney disease: a quality improvement initiative. BMJ Open Quality 2025; 14(4) doi: 10.1136/bmjoq-2025-003600
|
| 4 |
Muhammad Islampanah, Shaghayegh Karami, Sadaf Salehi, Abolfazl Akbari, Ali Noradini, Armin Tafazolimoghadam, Shayan Yousefi, Samira Pirzad. Veverimer in treating metabolic acidosis in chronic kidney disease patients: a systematic review and meta-analysis of randomized clinical trials. BMC Nephrology 2026; 27(1) doi: 10.1186/s12882-026-04821-4
|